Showing results (51-60 of 182) with videos related to
Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancerTiffany A Traina, Maria Theodoulou, Kimberly Feigin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2012
A phase I dose-escalation trial of trastuzumab and alvespimycin hydrochloride (KOS-1022; 17 DMAG) in the treatment of advanced solid tumorsKomal Jhaveri, Kathy Miller, Lee Rosen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
BRCA mutations in women with ductal carcinoma in situKaren Lisa Smith, Muriel Adank, Noah Kauff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Cardiac dysfunction in the trastuzumab clinical trials experienceAndrew Seidman, Clifford Hudis, Mary Kathryn Pierri, et al.Breast Cancer Research and Treatment|April 13, 2013
A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancerShanu Modi, Cristina Saura, Charles Henderson, et al.Cancer|August 27, 2004
Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomyTari A King, Archana Ganaraj, Jane V Fey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancerShanu Modi, Katherine S Panageas, Elaine T Duck, et al.Cancer Research|May 19, 2006
HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanismKotha Subbaramaiah, Louise R Howe, Elisa R Port, et al.Cureus|May 19, 2025
Successful Treatment of an Extensive Deep Vein Thrombosis in the Lower Left Extremity Through Thrombectomy and Endovascular Stenting: Role of May-Thurner Syndrome in Differential DiagnosesHong Thoai Nguyen, Chau Dang, Juveriya Yasmeen, et al.Breast Cancer Research and Treatment|October 8, 2017
Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impactDavid B Page, Hannah Wen, Edi Brogi, et al.Pageof 19